Vytrus Biotech S.A. (VYT) — Financial Flexibility Index
Vytrus Biotech S.A. (VYT) has a Financial Flexibility Index of 0.22x as of December 2022. Free cash flow of €719.71K (operating CF €225.55K minus capex €494.16K) represents 0% of total liabilities (€3.25 Million). Check VYT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vytrus Biotech S.A. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Vytrus Biotech S.A. across 6 annual periods. See how liquid is Vytrus Biotech S.A.'s working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Vytrus Biotech S.A. (2020–2025)
Year-by-year free cash flow to debt coverage for Vytrus Biotech S.A.. For the full company profile including market capitalisation, see VYT stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.51x | €6.58 Million | €3.90 Million | €4.35 Million | ▲ +90.3% |
| 2024 | 0.79x | €3.05 Million | €1.84 Million | €3.84 Million | ▲ +54.2% |
| 2023 | 0.51x | €2.07 Million | €904.39K | €4.02 Million | ▲ +132.5% |
| 2022 | 0.22x | €719.71K | €225.55K | €3.25 Million | ▼ -9.8% |
| 2021 | 0.25x | €719.74K | €447.92K | €2.93 Million | ▲ +520.1% |
| 2020 | 0.04x | €102.86K | €-132.47K | €2.60 Million | — |